HOXD9
Basic information
Region (hg38): 2:176122719-176124937
Previous symbols: [ "HOX4C", "HOX4" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the HOXD9 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 21 | 25 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 21 | 3 | 2 |
Variants in HOXD9
This is a list of pathogenic ClinVar variants found in the HOXD9 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-176122788-G-A | not specified | Uncertain significance (Aug 12, 2021) | ||
2-176122788-G-C | Benign (Jul 15, 2018) | |||
2-176122865-G-A | not specified | Uncertain significance (Sep 30, 2024) | ||
2-176122875-C-A | not specified | Uncertain significance (Dec 19, 2023) | ||
2-176122935-C-T | not specified | Uncertain significance (Jun 17, 2024) | ||
2-176122952-G-C | not specified | Uncertain significance (Jun 08, 2022) | ||
2-176122964-T-C | not specified | Uncertain significance (Feb 07, 2023) | ||
2-176123067-T-G | not specified | Uncertain significance (Apr 07, 2022) | ||
2-176123073-C-A | not specified | Uncertain significance (Dec 07, 2024) | ||
2-176123102-C-A | HOXD9-related disorder | Likely benign (Aug 09, 2022) | ||
2-176123105-G-T | not specified | Uncertain significance (Sep 10, 2024) | ||
2-176123115-T-C | not specified | Uncertain significance (Dec 04, 2024) | ||
2-176123121-C-T | not specified | Uncertain significance (Jul 06, 2021) | ||
2-176123186-G-A | not specified | Uncertain significance (Dec 12, 2023) | ||
2-176123226-C-G | not specified | Uncertain significance (Jun 01, 2023) | ||
2-176123231-G-C | HOXD9-related disorder | Likely benign (Mar 20, 2023) | ||
2-176123231-G-T | HOXD9-related disorder | Likely benign (Feb 28, 2023) | ||
2-176123234-C-A | not specified | Uncertain significance (Nov 30, 2021) | ||
2-176123312-A-G | not specified | Uncertain significance (Dec 19, 2023) | ||
2-176123313-C-T | not specified | Uncertain significance (Oct 24, 2024) | ||
2-176123354-G-A | not specified | Uncertain significance (Nov 08, 2024) | ||
2-176123358-G-A | not specified | Uncertain significance (Apr 12, 2024) | ||
2-176123373-G-A | not specified | Uncertain significance (Dec 09, 2024) | ||
2-176123406-T-C | not specified | Uncertain significance (Jun 30, 2024) | ||
2-176123418-C-A | not specified | Uncertain significance (Oct 04, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
HOXD9 | protein_coding | protein_coding | ENST00000249499 | 2 | 2766 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0170 | 0.898 | 125742 | 0 | 5 | 125747 | 0.0000199 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.578 | 147 | 168 | 0.875 | 0.00000781 | 2187 |
Missense in Polyphen | 49 | 60.999 | 0.8033 | 749 | ||
Synonymous | -0.973 | 82 | 71.5 | 1.15 | 0.00000364 | 751 |
Loss of Function | 1.45 | 4 | 8.58 | 0.466 | 3.72e-7 | 107 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000461 | 0.0000439 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Sequence-specific transcription factor which is part of a developmental regulatory system that provides cells with specific positional identities on the anterior-posterior axis.;
Haploinsufficiency Scores
- pHI
- 0.481
- hipred
- Y
- hipred_score
- 0.510
- ghis
- 0.444
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.883
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Hoxd9
- Phenotype
- cellular phenotype; muscle phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); endocrine/exocrine gland phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype;
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II;transcription, DNA-templated;single fertilization;skeletal muscle tissue development;adult locomotory behavior;anterior/posterior pattern specification;proximal/distal pattern formation;mammary gland development;embryonic forelimb morphogenesis;hindlimb morphogenesis;positive regulation of transcription by RNA polymerase II;embryonic skeletal system morphogenesis;peripheral nervous system neuron development
- Cellular component
- nucleus;nucleolus
- Molecular function
- RNA polymerase II regulatory region sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription repressor activity, RNA polymerase II-specific